MP Materials enters its third-quarter report with a story that has arguably improved on paper while the stock has gone the other way. Since the last update, the company added a nine-figure gadolinium supply deal with a U.S. aerospace and defense customer, launched a drone-magnet coordination effort it calls Project Swarm, and moved its 10X magnet plant into vertical construction. Yet the shares have fallen about 19% while the S&P 500 was essentially flat. The report due after the close on November 5 is less about headline earnings than about whether the operating machinery behind that strategic narrative is turning over on schedule.

Wall Street expects a loss of about a penny per share, and the Earnings Whisper sits at the same level, so there is no hidden bar above or below the published number. Revenue is forecast at roughly $117.1 million, more than double the $53.6 million of a year ago and modestly above the $108.5 million reported last quarter. That year-over-year leap mostly reflects how far NDPR volumes have climbed from last year's base. The sequential step is the more telling figure, because it implies MP delivers on its own production promise without much help from pricing.

That promise is the first thing to check. Management guided third-quarter NDPR oxide production above 1,000 metric tons, a rebound from 840 tons in the second quarter, when a planned biannual Mountain Pass shutdown ran longer than intended. Clearing that mark would confirm the dip was an outage rather than a reliability problem. Sales volumes topping 1,000 tons for a third straight quarter would also support the claim that demand still outruns supply. Falling short on production would raise awkward questions, since management framed sales volumes as roughly flat and there is little room to absorb a miss.

Pricing is the second swing factor, and here the cushion is shrinking. Management pointed to realized NDPR prices in the high $90s per kilogram, with only about $10 per kilogram coming from the government price-floor arrangement and minimal stockpile support. That is a long way from the $51 million of price-protection income booked in the fourth quarter of last year. With market prices hovering near the floor, the arrangement now functions more as a safety net than an earnings engine, so margin progress has to come from volume and cost. Management has already said cost-down benefits will build mainly through 2027, which means elevated staffing and startup expenses ahead of the heavy rare earth and chloralkali ramps could keep EBITDA soft.

The magnetics segment adds a third layer of noise. Roughly $46 million of prepaid precursor revenue is rolling off over three to four quarters, and startup costs can no longer be parked in inventory, so management warned results will be lumpy. Investors should look past segment volatility toward milestones: whether the dysprosium and terbium circuit has progressed from commissioning toward production, whether material is moving from Mountain Pass to the Independence facility, and whether General Motors commercial magnet shipments remain on track to begin in the fourth quarter. Cash, which fell to $1.45 billion as capital spending ran against a $500 million to $600 million annual budget, is worth tracking too.

Sentiment has cooled to barely bullish from somewhat more optimistic readings a quarter ago, and the stock trades near $41, well below its 200-day average of about $55.62 and close to the low end of its post-earnings range. That leaves expectations subdued. The central issue is whether MP can show that production has recovered and its heavy rare earth and magnet milestones are holding firm, because with price support fading, execution is now the only thing carrying the bull case.